(ESS) Essex Property Trust - Ratings and Ratios
Multifamily Properties, Apartments, Real Estate
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.59% |
| Yield on Cost 5y | 5.05% |
| Yield CAGR 5y | 5.00% |
| Payout Consistency | 99.4% |
| Payout Ratio | 2.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 21.9% |
| Value at Risk 5%th | 36.5% |
| Relative Tail Risk | 1.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.26 |
| Alpha | -16.75 |
| CAGR/Max DD | 0.45 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.441 |
| Beta | 0.629 |
| Beta Downside | 0.822 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.07% |
| Mean DD | 7.35% |
| Median DD | 6.91% |
Description: ESS Essex Property Trust December 19, 2025
Essex Property Trust (NYSE:ESS) is an S&P 500 REIT that focuses on acquiring, developing, redeveloping, and managing multifamily residential assets across select West Coast markets. The company presently holds ownership stakes in 257 apartment communities, totaling more than 62,000 units, and has at least one additional property under active development.
Key performance indicators as of the most recent FY 2023 filing show an occupancy rate of roughly 96%, a funds-from-operations (FFO) growth of 8% year-over-year, and a leverage ratio (net debt to total assets) of about 55%, placing Essex in the mid-range of industry leverage norms.
The West Coast multifamily sector is driven by strong population inflows, limited new supply due to zoning constraints, and relatively resilient rent growth-average annual rent increases of 4-5% in the company’s core markets. However, rising interest rates could pressure cap-rate compression and affect acquisition financing costs.
For a deeper, data-rich analysis of ESS’s valuation dynamics, consider exploring the detailed metrics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 846.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.21 > 1.0 |
| NWC/Revenue: -17.29% < 20% (prev -0.82%; Δ -16.47% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.06b > Net Income 846.5m |
| Net Debt (6.65b) to EBITDA (1.62b): 4.11 < 3 |
| Current Ratio: 0.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.4m) vs 12m ago 0.23% < -2% |
| Gross Margin: 60.02% > 18% (prev 0.82%; Δ 5920 % > 0.5%) |
| Asset Turnover: 14.44% > 50% (prev 13.77%; Δ 0.67% > 0%) |
| Interest Coverage Ratio: 4.02 > 6 (EBITDA TTM 1.62b / Interest Expense TTM 252.6m) |
Altman Z'' -0.05
| A: -0.02 (Total Current Assets 381.0m - Total Current Liabilities 703.0m) / Total Assets 13.15b |
| B: -0.08 (Retained Earnings -1.06b / Total Assets 13.15b) |
| C: 0.08 (EBIT TTM 1.01b / Avg Total Assets 12.90b) |
| D: -0.14 (Book Value of Equity -1.06b / Total Liabilities 7.32b) |
| Altman-Z'' Score: -0.05 = B |
Beneish M -2.63
| DSRI: 1.03 (Receivables 221.6m/200.3m, Revenue 1.86b/1.74b) |
| GMI: 1.36 (GM 60.02% / 81.90%) |
| AQI: 1.01 (AQ_t 0.97 / AQ_t-1 0.96) |
| SGI: 1.07 (Revenue 1.86b / 1.74b) |
| TATA: -0.02 (NI 846.5m - CFO 1.06b) / TA 13.15b) |
| Beneish M-Score: -2.63 = A |
ValueRay F-Score (Strict, 0-100) 66.68
| 1. Piotroski: 4.50pt |
| 2. FCF Yield: 3.77% |
| 3. FCF Margin: 49.34% |
| 4. Debt/Equity: 1.19 |
| 5. Debt/Ebitda: 4.11 |
| 6. ROIC - WACC: 0.35% |
| 7. RoE: 15.13% |
| 8. Revenue Trend: 97.62% |
| 9. EPS Trend: -11.06% |
What is the price of ESS shares?
Over the past week, the price has changed by -1.62%, over one month by -1.19%, over three months by -2.71% and over the past year by -5.03%.
Is ESS a buy, sell or hold?
- Strong Buy: 3
- Buy: 6
- Hold: 16
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the ESS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 282.3 | 11.1% |
| Analysts Target Price | 282.3 | 11.1% |
| ValueRay Target Price | 264.6 | 4.1% |
ESS Fundamental Data Overview January 22, 2026
P/E Forward = 42.9185
P/S = 9.2339
P/B = 2.9538
P/EG = 7.395
Revenue TTM = 1.86b USD
EBIT TTM = 1.01b USD
EBITDA TTM = 1.62b USD
Long Term Debt = 6.42b USD (from longTermDebt, last quarter)
Short Term Debt = 245.0m USD (from shortTermDebt, last quarter)
Debt = 6.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.65b USD (from netDebt column, last quarter)
Enterprise Value = 24.35b USD (17.70b + Debt 6.71b - CCE 66.0m)
Interest Coverage Ratio = 4.02 (Ebit TTM 1.01b / Interest Expense TTM 252.6m)
EV/FCF = 26.50x (Enterprise Value 24.35b / FCF TTM 918.9m)
FCF Yield = 3.77% (FCF TTM 918.9m / Enterprise Value 24.35b)
FCF Margin = 49.34% (FCF TTM 918.9m / Revenue TTM 1.86b)
Net Margin = 45.46% (Net Income TTM 846.5m / Revenue TTM 1.86b)
Gross Margin = 60.02% ((Revenue TTM 1.86b - Cost of Revenue TTM 744.4m) / Revenue TTM)
Gross Margin QoQ = 69.69% (prev 68.62%)
Tobins Q-Ratio = 1.85 (Enterprise Value 24.35b / Total Assets 13.15b)
Interest Expense / Debt = 0.94% (Interest Expense 63.3m / Debt 6.71b)
Taxrate = 21.0% (US default 21%)
NOPAT = 801.3m (EBIT 1.01b * (1 - 21.00%))
Current Ratio = 0.54 (Total Current Assets 381.0m / Total Current Liabilities 703.0m)
Debt / Equity = 1.19 (Debt 6.71b / totalStockholderEquity, last quarter 5.63b)
Debt / EBITDA = 4.11 (Net Debt 6.65b / EBITDA 1.62b)
Debt / FCF = 7.24 (Net Debt 6.65b / FCF TTM 918.9m)
Total Stockholder Equity = 5.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.56% (Net Income 846.5m / Total Assets 13.15b)
RoE = 15.13% (Net Income TTM 846.5m / Total Stockholder Equity 5.59b)
RoCE = 8.45% (EBIT 1.01b / Capital Employed (Equity 5.59b + L.T.Debt 6.42b))
RoIC = 6.52% (NOPAT 801.3m / Invested Capital 12.30b)
WACC = 6.17% (E(17.70b)/V(24.41b) * Re(8.23%) + D(6.71b)/V(24.41b) * Rd(0.94%) * (1-Tc(0.21)))
Discount Rate = 8.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.18%
[DCF Debug] Terminal Value 85.53% ; FCFF base≈915.3m ; Y1≈943.4m ; Y5≈1.06b
Fair Price DCF = 345.8 (EV 28.92b - Net Debt 6.65b = Equity 22.27b / Shares 64.4m; r=6.17% [WACC]; 5y FCF grow 3.09% → 2.90% )
EPS Correlation: -11.06 | EPS CAGR: -7.18% | SUE: -0.20 | # QB: 0
Revenue Correlation: 97.62 | Revenue CAGR: 6.66% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.46 | Chg30d=-0.010 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=6.01 | Chg30d=-0.022 | Revisions Net=+3 | Growth EPS=+3.5% | Growth Revenue=+3.4%
Additional Sources for ESS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle